Oxford Events, the new replacement for OxTalks, will launch on 16th March. From now until the launch of Oxford Events, new events cannot be published or edited on OxTalks while all existing records are migrated to the new platform. The existing OxTalks site will remain available to view during this period.
From 16th, Oxford Events will launch on a new website: events.ox.ac.uk, and event submissions will resume. You will need a Halo login to submit events. Full details are available on the Staff Gateway.
Dr. James Olzmann completed his undergraduate studies in Biology at the University of Michigan and earned his Ph.D. in Neuroscience at Emory University. He then performed his postdoctoral research in the laboratory of Dr. Ron Kopito at Stanford University, where he studied the cellular mechanisms of ER protein quality control. In 2013, he established his independent research group at the University of California, Berkeley where he is the Doris H. Calloway Chair and Professor of Molecular Therapeutics. He holds a joint appointment in the Departments of Molecular & Cell Biology and Nutritional Sciences & Toxicology. Dr. Olzmann’s research group investigates the principles that regulate cellular lipid homeostasis, including the mechanisms that influence neutral lipid storage in lipid droplets and oxidative lipid damage during ferroptosis. His group further aims to develop small molecule tools and therapeutics to target these pathways in disease. Dr. Olzmann’s contributions to the field have been recognized with several honors, such as the Presidential Early Career Award for Scientists and Engineers, American Society for Cell Biology Günter Blobel Early Career Award, Chan Zuckerberg Biohub Investigator appointment, UC Berkeley Beatriz Manz Award, and Miller Institute Professorship Award.
